Sales and Marketing

When creating engagement plans for individual Digital Key Opinion Leaders (DOLs), it’s best to look at a range

Data-Led Digital KOL Engagement

https://pharmaphorum.com/partner-content/data-led-digital-kol-engagement/

Mallinckrodt tries again with kidney drug terlipressin

Phil Taylor kidney disease, Mallinckrodt, regulatory, terlipressin 0 Comment

Manufacturing problems wreaked havoc with Mallinckrodt’s first attempt to secure FDA approval of its treatment candidate terlipressin for

Mallinckrodt tries again with kidney drug terlipressin

https://pharmaphorum.com/news/mallinckrodt-tries-again-with-kidney-drug-terlipressin/

Market Access/ News/ News/ News/ Sales and Marketing

Alnylam grabs FDA approval for its second amyloidosis therapy

Phil Taylor Alnylam Pharmaceuticals, Amvuttra, ATTR amyloidosis, Ionis Pharmaceuticals, Onpattro, regulatory approval, SOBI, Tegsedi 0 Comment

Four years after getting the first drug approved by the FDA to treat rare disease hereditary ATTR amyloidosis,

Alnylam grabs FDA approval for its second amyloidosis therapy

https://pharmaphorum.com/news/alnylam-grabs-fda-approval-for-its-second-amyloidosis-therapy/

Market Access/ News/ News/ News/ Sales and Marketing

Lilly’s Olumiant okayed in alopecia, with Pfizer, Concert in hot pursuit

Phil Taylor alopecia, Concert Pharma, Eli Lilly, Incyte, JAK inhibitor, Olumiant, Pfizer 0 Comment

Eli Lilly and Incyte’s Olumiant has secured the first FDA approval for a systemic drug to treat alopecia

Lilly’s Olumiant okayed in alopecia, with Pfizer, Concert in hot pursuit

https://pharmaphorum.com/news/lillys-olumiant-okayed-in-alopecia-with-pfizer-concert-in-hot-pursuit/

Tablets on dollar bills (treatment, addiction, aging - concept).

News/ News/ Sales and Marketing

FTC launches probe into pharmacy benefit management sector

Phil Taylor CVS Caremark, Drug pricing, Express Scripts, Federal Trade Commission, Humana, MedImpact Healthcare Systems, OptumRx, pharmacy benefit manager, Prime Therapeutics 0 Comment

Longstanding claims that one of the reasons for high drug prices in the US is the actions of

FTC launches probe into pharmacy benefit management sector

https://pharmaphorum.com/news/ftc-launches-probe-into-pharmacy-benefit-management-sector/

Sales and Marketing/ Views & Analysis/ Views and analysis

Simple ways to support a presenter and benefit from their talk

Oliver Stohlmann communication, Corporate Survival Hacks, work environment 0 Comment

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life

Simple ways to support a presenter and benefit from their talk

https://pharmaphorum.com/sales-marketing/simple-ways-to-support-a-presenter-and-benefit-from-their-talk/

Oncology/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

Redefining the approach to cancer care – a mission to improve patient outcomes

mike.hammerton@pharmaphorum.com breast cancer, cancer care, company profile, Exact Sciences, her2 0 Comment

Each year across Europe, 3.7 million people are diagnosed with a form of cancer, resulting in 1.9 million

Redefining the approach to cancer care – a mission to improve patient outcomes

https://pharmaphorum.com/oncology/redefining-the-approach-to-cancer-care-a-mission-to-improve-patient-outcomes/

Digital/ News/ News/ News/ Sales and Marketing

Eversana aims athletes’ mental coaching at pharma sales reps

Phil Taylor digital, Sales reps, Training 0 Comment

Eversana’s suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training

Eversana aims athletes’ mental coaching at pharma sales reps

https://pharmaphorum.com/news/eversana-aims-athletes-mental-coaching-at-pharma-sales-reps/

News/ News/ Sales and Marketing

Pfizer will exit GSK consumer health JV after spinout

Phil Taylor consumer health, Financial, GlaxoSmithKline, Haleon, M&A, Pfizer 0 Comment

GlaxoSmithKline is due to complete the split from its consumer health decision – now renamed Haleon – next

Pfizer will exit GSK consumer health JV after spinout

https://pharmaphorum.com/news/pfizer-will-exit-gsk-consumer-health-jv-after-spinout/

‹ 1 2 3 4 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

Sales and Marketing

Login